Beschreibung:
<jats:title>Abstract</jats:title>
<jats:sec>
<jats:title>Introduction</jats:title>
<jats:p>Greater trochanter pain syndrome (GTPS) is characterized by a persistent and debilitating pain around the greater trochanter. GTPS can be caused by a combination of gluteus medius or minimus tendinopathy, snapping hip or trochanteric bursitis.</jats:p>
</jats:sec>
<jats:sec>
<jats:title>Source of data</jats:title>
<jats:p>Recent published literatures identified from PubMed, EMBASE, Google Scholar, Scopus.</jats:p>
</jats:sec>
<jats:sec>
<jats:title>Areas of agreement</jats:title>
<jats:p>Platelet rich plasma (PRP) and corticosteroids (CCS) injections are useful options to manage symptoms of GTPS.</jats:p>
</jats:sec>
<jats:sec>
<jats:title>Areas of controversy</jats:title>
<jats:p>Whether PRP leads to superior outcomes compared to CCS injections is unclear.</jats:p>
</jats:sec>
<jats:sec>
<jats:title>Growing points</jats:title>
<jats:p>A systematic review and meta-analysis comparing PRP versus CCS in the management of GTPS was conducted.</jats:p>
</jats:sec>
<jats:sec>
<jats:title>Areas timely for developing research</jats:title>
<jats:p>PRP injections are more effective than CCS at approximately 2 years follow-up.</jats:p>
</jats:sec>